Cybin Inc.
CYBNAMEXHealthcare
$8.28
+$0.10(+1.22%)
Market Cap$413023556
P/E Ratio—
52W High$10.7199
52W Low$4.81
Cybin Inc. (CYBN) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CYBN · earnings · updated Jun 9, 2026
Latest Earnings
Q1 FY2026Report Date: Feb 9, 2026EPS Actual
-$0.38
Est. -$0.53 · +28.3%
Revenue
—
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Feb 9, 2026
After Market Close
▲ Beat EPS✓ 1-Quarter EPS Beat Streak
CYBN reports quarterly as a AMEX-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ▲ Q1 FY2026 | Feb 9, 2026 | -$0.53 | -$0.38 | +28.3% | — | — | — |
| ▼ Q4 FY2025 | Nov 13, 2025 | -$0.74 | -$1.39 | -87.8% | — | — | — |
| ▼ Q3 FY2025 | Aug 13, 2025 | -$0.51 | -$1.10 | -115.7% | — | — | — |
| ▼ Q2 FY2025 | Jun 30, 2025 | -$0.51 | -$1.02 | -100.0% | — | — | — |
| ▲ Q1 FY2025 | Feb 10, 2025 | -$0.51 | -$0.38 | +25.5% | — | — | — |
| ▼ Q4 FY2024 | Nov 13, 2024 | -$0.38 | -$2.10 | -452.6% | — | — | — |
| ▼ Q3 FY2024 | Aug 8, 2024 | -$0.02 | -$0.38 | -1800.0% | — | — | — |
| — Q1 FY2024 | Mar 31, 2024 | — | -$0.12 | — | — | — | — |
Q1 FY2026
Feb 9, 2026Beat
EPS Actual
-$0.38
EPS Est.
-$0.53
EPS Surpr.
+28.3%
Revenue
—
Q4 FY2025
Nov 13, 2025Miss
EPS Actual
-$1.39
EPS Est.
-$0.74
EPS Surpr.
-87.8%
Revenue
—
Q3 FY2025
Aug 13, 2025Miss
EPS Actual
-$1.10
EPS Est.
-$0.51
EPS Surpr.
-115.7%
Revenue
—
Q2 FY2025
Jun 30, 2025Miss
EPS Actual
-$1.02
EPS Est.
-$0.51
EPS Surpr.
-100.0%
Revenue
—
Q1 FY2025
Feb 10, 2025Beat
EPS Actual
-$0.38
EPS Est.
-$0.51
EPS Surpr.
+25.5%
Revenue
—
Q4 FY2024
Nov 13, 2024Miss
EPS Actual
-$2.10
EPS Est.
-$0.38
EPS Surpr.
-452.6%
Revenue
—
Q3 FY2024
Aug 8, 2024Miss
EPS Actual
-$0.38
EPS Est.
-$0.02
EPS Surpr.
-1800.0%
Revenue
—
Q1 FY2024
Mar 31, 2024
EPS Actual
-$0.12
EPS Est.
—
EPS Surpr.
—
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2027 | $-0.56 | $-0.56 | $-0.56 | 1 |
| Q4 FY2026 | $-0.59 | $-0.59 | $-0.59 | 1 |
| Q3 FY2026 | $-0.62 | $-0.62 | $-0.62 | 1 |
| Q2 FY2026 | $-0.61 | $-0.61 | $-0.61 | 1 |
| Q1 FY2026 | $-0.58 | $-0.58 | $-0.58 | 2 |
| Q4 FY2025 | $-0.59 | $-0.59 | $-0.59 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
| Q1 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q1 FY2026 | Feb 9, 2026 | +28.3% | $6.77 | — | — |
| ▼ Q4 FY2025 | Nov 13, 2025 | -87.8% | $6.46 | $5.94 | -8.05% |
| ▼ Q3 FY2025 | Aug 13, 2025 | -115.7% | $7.63 | $7.60 | -0.39% |
| ▼ Q2 FY2025 | Jun 30, 2025 | -100.0% | $8.15 | $8.39 | +2.94% |
| ▲ Q1 FY2025 | Feb 10, 2025 | +25.5% | $9.00 | $9.37 | +4.11% |
| ▼ Q4 FY2024 | Nov 13, 2024 | -452.6% | $11.70 | $10.50 | -10.26% |
| ▼ Q3 FY2024 | Aug 8, 2024 | -1800.0% | $10.07 | $10.30 | +2.28% |
| — Q1 FY2024 | Mar 31, 2024 | — | $15.71 | $16.12 | +2.61% |
Q1 FY2026—
Report Date
Feb 9, 2026
EPS Beat/Miss
+28.3%
Price Before
$6.77
Price After
—
Q4 FY2025-8.05%
Report Date
Nov 13, 2025
EPS Beat/Miss
-87.8%
Price Before
$6.46
Price After
$5.94
Q3 FY2025-0.39%
Report Date
Aug 13, 2025
EPS Beat/Miss
-115.7%
Price Before
$7.63
Price After
$7.60
Q2 FY2025+2.94%
Report Date
Jun 30, 2025
EPS Beat/Miss
-100.0%
Price Before
$8.15
Price After
$8.39
Q1 FY2025+4.11%
Report Date
Feb 10, 2025
EPS Beat/Miss
+25.5%
Price Before
$9.00
Price After
$9.37
Q4 FY2024-10.26%
Report Date
Nov 13, 2024
EPS Beat/Miss
-452.6%
Price Before
$11.70
Price After
$10.50
Q3 FY2024+2.28%
Report Date
Aug 8, 2024
EPS Beat/Miss
-1800.0%
Price Before
$10.07
Price After
$10.30
Q1 FY2024+2.61%
Report Date
Mar 31, 2024
EPS Beat/Miss
—
Price Before
$15.71
Price After
$16.12
Avg Beat Reaction+4.11%
Avg Miss Reaction-2.70%
Beat Rate2 / 8 quarters
Largest Move-10.26% (Q4 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CYBN ends December
Cybin Inc. (CYBN) most recently reported earnings on February 9, 2026 for Q1 FY2026, posting EPS of $-0.38 — beating the analyst consensus of $-0.53 by +28.3%. The next CYBN earnings date is expected around September 1, 2026.
Each quarter, investors track CYBN earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CYBN revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CYBN's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CYBN earnings · 5 questionsCybin Inc.'s next earnings report is expected around September 1, 2026. CYBN typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CYBN historically reports after market close (AMC).
CYBN earnings datewhen is CYBN earningsCYBN next earnings datewhen does CYBN report earningsCYBN earnings calendar
▸ Source: FMP · Cybin Inc. SEC filings · US GAAP · Cybin Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026